EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.

por Mototaka Sato, Yasutomo Nakai, Wataru Nakata, Takahiro Yoshida, Koji Hatano, Atsunari Kawashima, Kazutoshi Fujita, Motohide Uemura, Hitoshi Takayama, Norio Nonomura
Publicado 2013

Decreased renal function increases the nighttime urine volume rate by carryover of salt excretion to the nighttime

por Kentaro Takezawa, Sohei Kuribayashi, Koichi Okada, Yosuke Sekii, Yusuke Inagaki, Shinichiro Fukuhara, Hiroshi Kiuchi, Toyofumi Abe, Kazutoshi Fujita, Motohide Uemura, Ryoichi Imamura, Norio Nonomura
Publicado 2021